{
  "_id": "ba6e8f4ed3374a971f8cdeb2d62eb8c496201eb9105125825b4ce702c92035a7",
  "feed": "market-watch",
  "title": "Merck nears deal for rare-disease-drug maker Acceleron",
  "text": "<p>Should a deal come together, it would be one of Merck's MRK biggest and represent a bet on the treatments for the respiratory and blood diseases that Acceleron XLRN specializes in.</p><p>Merck appears to have beaten out other potential suitors for Acceleron including Bristol Myers Squibb Co., BMY which already owns a big stake in the company.</p><p>An expanded version of this story is available at WSJ.com</p>",
  "published": "2021-09-28T03:20:00.000Z",
  "tags": [
    {
      "id": "US58933Y1055",
      "name": "Merck & Co., Inc.",
      "offsets": [
        {
          "start": 48,
          "end": 53
        },
        {
          "start": 181,
          "end": 186
        },
        {
          "start": 0,
          "end": 5
        }
      ],
      "nexusId": "10042334"
    }
  ]
}